232 related articles for article (PubMed ID: 25889236)
1. Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors.
Taddeo A; Khodadadi L; Voigt C; Mumtaz IM; Cheng Q; Moser K; Alexander T; Manz RA; Radbruch A; Hiepe F; Hoyer BF
Arthritis Res Ther; 2015 Mar; 17(1):39. PubMed ID: 25889236
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice.
Khodadadi L; Cheng Q; Alexander T; Sercan-Alp Ö; Klotsche J; Radbruch A; Hiepe F; Hoyer BF; Taddeo A
PLoS One; 2015; 10(8):e0135081. PubMed ID: 26252021
[TBL] [Abstract][Full Text] [Related]
3. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
[TBL] [Abstract][Full Text] [Related]
5. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
6. CXCR4-CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice.
Cheng Q; Khodadadi L; Taddeo A; Klotsche J; F Hoyer B; Radbruch A; Hiepe F
Eur J Immunol; 2018 Jun; 48(6):1020-1029. PubMed ID: 29427452
[TBL] [Abstract][Full Text] [Related]
7. Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
Taylor EB; Barati MT; Powell DW; Turbeville HR; Ryan MJ
Hypertension; 2018 Apr; 71(4):719-728. PubMed ID: 29378858
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.
Mumtaz IM; Hoyer BF; Panne D; Moser K; Winter O; Cheng QY; Yoshida T; Burmester GR; Radbruch A; Manz RA; Hiepe F
J Autoimmun; 2012 Sep; 39(3):180-8. PubMed ID: 22727274
[TBL] [Abstract][Full Text] [Related]
9. Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.
Wang W; Rangel-Moreno J; Owen T; Barnard J; Nevarez S; Ichikawa HT; Anolik JH
J Immunol; 2014 Apr; 192(7):3011-20. PubMed ID: 24574498
[TBL] [Abstract][Full Text] [Related]
10. Proteasome Inhibition with Bortezomib Induces Apoptosis of Long-Lived Plasma Cells in Steroid-Resistant or Relapsed Immune Thrombocytopaenia.
Li G; Wang S; Li N; Liu Y; Feng Q; Zuo X; Li X; Hou Y; Shao L; Ma C; Gao C; Hou M; Peng J
Thromb Haemost; 2018 Oct; 118(10):1752-1764. PubMed ID: 30235480
[TBL] [Abstract][Full Text] [Related]
11. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
12. Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice.
Trigunaite A; Khan A; Der E; Song A; Varikuti S; Jørgensen TN
Arthritis Rheum; 2013 Sep; 65(9):2392-402. PubMed ID: 23754362
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors.
Alexander T; Cheng Q; Klotsche J; Khodadadi L; Waka A; Biesen R; Hoyer BF; Burmester GR; Radbruch A; Hiepe F
Eur J Immunol; 2018 Sep; 48(9):1573-1579. PubMed ID: 29979809
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
[TBL] [Abstract][Full Text] [Related]
15. Analyzing pathogenic (double-stranded (ds) DNA-specific) plasma cells via immunofluorescence microscopy.
Winter O; Musiol S; Schablowsky M; Cheng Q; Khodadadi L; Hiepe F
Arthritis Res Ther; 2015 Oct; 17():293. PubMed ID: 26490351
[TBL] [Abstract][Full Text] [Related]
16. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
Alexander T; Sarfert R; Klotsche J; Kühl AA; Rubbert-Roth A; Lorenz HM; Rech J; Hoyer BF; Cheng Q; Waka A; Taddeo A; Wiesener M; Schett G; Burmester GR; Radbruch A; Hiepe F; Voll RE
Ann Rheum Dis; 2015 Jul; 74(7):1474-8. PubMed ID: 25710470
[TBL] [Abstract][Full Text] [Related]
17. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.
Neubert K; Meister S; Moser K; Weisel F; Maseda D; Amann K; Wiethe C; Winkler TH; Kalden JR; Manz RA; Voll RE
Nat Med; 2008 Jul; 14(7):748-55. PubMed ID: 18542049
[TBL] [Abstract][Full Text] [Related]
18. Honeybee royal jelly inhibits autoimmunity in SLE-prone NZB x NZW F1 mice.
Mannoor MK; Shimabukuro I; Tsukamotoa M; Watanabe H; Yamaguchi K; Sato Y
Lupus; 2009 Jan; 18(1):44-52. PubMed ID: 19074168
[TBL] [Abstract][Full Text] [Related]
19. BAFF and CD4
Thai LH; Le Gallou S; Robbins A; Crickx E; Fadeev T; Zhou Z; Cagnard N; Mégret J; Bole C; Weill JC; Reynaud CA; Mahévas M
Blood; 2018 Apr; 131(14):1545-1555. PubMed ID: 29378696
[TBL] [Abstract][Full Text] [Related]
20. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
Mina-Osorio P; LaStant J; Keirstead N; Whittard T; Ayala J; Stefanova S; Garrido R; Dimaano N; Hilton H; Giron M; Lau KY; Hang J; Postelnek J; Kim Y; Min S; Patel A; Woods J; Ramanujam M; DeMartino J; Narula S; Xu D
Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
